Diabetes Ten City Challenge Interim Results Show Improved Patient Health Across Key Clinical and Patient Satisfaction Indicators Data Proves Collaborative Care Model is Working for Nearly 1,000 Participants Interim results published in the Marc

Video Transcription

Every 21 seconds, another American is diagnosed with diabetes. The sixth leading cause of death in the United States. Male: The diabetes epidemic is one of the greatest challenges facing the US healthcare system today. Over 20 million people have diabetes and this year alone, over 200,000 people will die. In addition, there are a number of complications facing people with diabetes including blindness, kidney failure and problems with the lower extremities. The US spends over $174 billion a year on diabetes, measured in the direct and indirect cause of emergency room visits. Expensive and extensive hospitalizations, disability, insurance costs, absenteeism and lost worker productivity. In an effort to address these critical issues, in October 2005, the American Pharmacist Association Foundation announced the diabetes ten-city challenge with support from Glaxo-SmithKline. Male: Through the diabetes ten-city challenge, employers provide a voluntary health benefit for their employees and their families and it provides incentives such as waived copays for diabetes medications and supplies, and it also provides access to the support services of a pharmacist coach to help patients manage their disease on a day to day basis. Chronic diseases like diabetes are threatening the stability of our healthcare system. By focusing on patients and helping them to better understand and self manage their condition, we can improve their health and lower cost. So GSK is proud to support the diabetes ten-city challenge because it is a model that works and it can be replicated. Today, 31 employers and hundreds of local pharmacist in ten cities have joined together to help more than one thousand employees, dependents and retirees manage their diabetes. Female: By providing the participants their medications and supply at no cost and you waive any financial barriers that will prohibit them from taking control of their chronic disease. This results in improved health and when they see their pharmacists that is where they stay accountable for setting goals, staying on track and learning everything they need to control their chronic disease. In an interim report published in the March issue of the Journal of the American Pharmacist Association, DTCC participants improved across all key diabetes indicators including a 21% increase in people achieving and A1c goal less than seven. More than 57% of participants are achieving LDL cholesterol goals. A 15.7% increase in the number of people achieving blood pressure goals. The interim report also looked at patient satisfaction and lifestyle goals. The number of participants with nutrition goals increased from 22% to 66%. The number of people with weight goals increased from 23% to 64% and the number of participants with exercise goals increased from 24% to 72%. Male: The data clearly show that when patients are supported and empowered to make the lifestyle changes that are necessary to manage a chronic disease such as diabetes with significant clinical improvements are possible. Female: I work closely with each of my patients to monitor key diabetes indicators—I also educate them on diet, exercise, their medications and the importance of vaccinations and we work together to formulate appropriate lifestyle goals. My ultimate goal is for my patients to have the skills to manage their diabetes and ultimately to improve the quality of their life. Male2: Now, the program is really incredible. Since joining the program, my pharmacist coach has helped me control my diabetes as well as my cholesterol and blood pressure and they helped me to understand my readings and my current medications. We also got her set up a little exercise program that I do for my home and I just feel that the program and with the help of the pharmacists, I have more control over my diabetes and the diabetes does not have control over me. In 2007, the APHA foundation announced, Health Map Rx, an initiative that offers the DTCC collaborative model of care to employers nationwide. Male2: The cost of chronic disease in this country are nearing catastrophic proportions when look at it in terms of clinical, economic and humanistic costs. Programs such as the diabetes ten-city challenge and Health Map Rx are fundamentally changing the way we manage and pay for a chronic disease in this country because they align the incentives for all stakeholders, most importantly the patient. The diabetes ten-city challenge, empowering people and changing health care in the US.